Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18275388 | METHODS FOR TREATING AND AMELIORATING CANCER | Non-Final OA | The Regents of the University of California |
| 17928496 | COMPOSITIONS AND METHODS FOR TREATING VIRUS INFECTION | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18033178 | METHODS TO SENSITIZE TUMORS TO TREATMENT BY IMMUNOTHERAPY | Final Rejection | Ohio State Innovation Foundation |
| 18257677 | SELECTIVE HDAC6 INHIBITOR | Non-Final OA | DANA-FARBER CANCER INSTITUTE, INC. |
| 18265030 | METHOD OF TREATING AND PREVENTING VIRAL INFECTION | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 17919726 | COMBINATION THERAPY OF ARTEMISININ-RELATED COMPOUNDS AND HISTONE DEACETYLASE INHIBITORS FOR TREATMENT OF HPV-RELATED BENIGN, PREMALIGNANT, AND MALIGNANT DISEASES | Non-Final OA | Georgetown University |
| 18220090 | INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 18269086 | 2H-INDAZOLE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE | Non-Final OA | BIOGEN MA INC. |
| 18268440 | SUBSTITUTED INDOLE COMPOUNDS | Final Rejection | Gilead Sciences, Inc. |
| 18627415 | Treatment of Respiratory Diseases | Non-Final OA | TIANLI BIOTECH PTY LTD |
| 18560341 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | Non-Final OA | Jazz Pharmaceuticals Research UK Limited |
| 18287743 | COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Non-Final OA | CHONG KUN DANG PHARMACEUTICAL CORP. |
| 17995947 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Non-Final OA | CHONG KUN DANG PHARMACEUTICAL CORP. |
| 18285812 | GPR119 AGONISTS | Non-Final OA | Kallyope, Inc. |
| 18284253 | PREPARATION METHOD OF QUINOLINE DERIVATIVE COMPOUNDS | Non-Final OA | INSTITUT CURIE |
| 18236560 | FUSED HETEROBICYCLIC ANTIVIRAL AGENTS | Non-Final OA | ENANTA PHARMACEUTICALS, INC. |
| 18259306 | PYRIMIDO-HETEROCYCLIC COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Final Rejection | SHANGHAI RINGENE BIOPHARMA CO., LTD. |
| 17760329 | USP7 INHIBITOR FOR USE IN THE TREATMENT OF CANCER | Non-Final OA | ALMAC DISCOVERY LIMITED |
| 17998445 | PREPARATION OF BIARYL RING-LINKED AROMATIC HETEROCYCLIC DERIVATIVE AS IMMUNOMODULATOR AND USE THEREOF | Final Rejection | SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD. |
| 18039895 | GPX4 PROTEIN DEGRADATION-INDUCING COMPOUND | Non-Final OA | UPPTHERA |
| 18325930 | CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL ADJUVANT THERAPIES | Final Rejection | CytoAgents, Inc. |
| 18314047 | NALTREXONE AND RISPERIDONE COMBINATION SUSTAINED-RELEASE COMPOSITION | Final Rejection | SHENZHEN SCIENCARE MEDICAL INDUSTRIES CO., |
| 18006908 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | Final Rejection | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA |
| 17970293 | METHODS FOR MODULATION OF LIPOPROTEIN LIPASE AND APOLIPOPROTEIN C2 EXPRESSION AND/OR ACTIVITY IN THE TREATMENT OF PERIPHERAL AND CENTRAL NERVOUS SYSTEM TISSUE DISEASE STATES | Non-Final OA | ENDECE LLC |
| 17641734 | COMPOSITION FOR PREVENTING AND TREATING TAUOPATHIES | Non-Final OA | UNIVERSIDAD DE MALÁGA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy